重组Anti-IL-1 beta抗体[RM1009] (ab283818)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit recombinant multiclonal [RM1009] to IL-1 beta
- Suitable for: IHC-P, WB, ICC, IP, Flow Cyt
- Knockout validated
- Reacts with: Mouse, Rat, Human
Related conjugates and formulations
概述
-
产品名称
Anti-IL-1 beta抗体[RM1009]
参阅全部 IL-1 beta 一抗 -
描述
兔重组multiclonal [RM1009] to IL-1 beta -
宿主
Rabbit -
特异性
IL-1 beta is not present under homeostatic conditions, and it is induced and secreted only upon inflammatory signals. Stimulation may be required for the detection of IL-1β, no matter in precursor or mature form (PMID: 22019906). IL-1β is a secreted protein, it is recommended to treat cells with anti-secretion reagents (e.g. Brefeldin A) when test IL-1β using whole cell lysate in WB.
-
经测试应用
适用于: IHC-P, WB, ICC, IP, Flow Cytmore details -
种属反应性
与反应: Mouse, Rat, Human -
免疫原
This product was produced with the following immunogens:
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers. -
阳性对照
- WB: U-87 MG ; PMA, LPS & BFA treated U-937 ; LPS & BFA treated RAW 264.7 & NR8383 whole cell lysates. IHC-P: Mouse colon carcinoma tissue ; LPS & BFA treated Mouse lung tissue & RAW 264.7. ICC: PMA, LPS & BFA treated U-937 cells ; LPS & BFA treated J774A.1 & RAW 264.7 cells. Flow cyt: PMA, LPS & BFA treated U-937 cells ; LPS & BFA treated J774A.1 cells. IP: PMA, LPS & BFA treated U-937 cells ; LPS & BFA treated J774A.1 & RAW 264.7 cells.
-
常规说明
This product is a recombinant multiclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
For more information see here.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
存储溶液
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
克隆
Recombinant Multiclonal -
克隆编号
RM1009 -
同种型
IgG -
研究领域
相关产品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Related Products
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab283818于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-P |
1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Not recommended for rat or human. |
|
WB |
1/1000.
|
|
ICC |
1/50.
|
|
IP |
1/30.
|
|
Flow Cyt |
1/500.
|
说明 |
---|
IHC-P
1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. Not recommended for rat or human. |
WB
1/1000. |
ICC
1/50. |
IP
1/30. |
Flow Cyt
1/500. |
靶标
-
功能
Potent proinflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production. Promotes Th17 differentiation of T-cells. -
组织特异性
Expressed in activated monocytes/macrophages (at protein level). -
序列相似性
Belongs to the IL-1 family. -
翻译后修饰
Activation of the IL1B precursor involves a CASP1-catalyzed proteolytic cleavage. Processing and secretion are temporarily associated. -
细胞定位
Cytoplasm, cytosol. Lysosome. Secreted, exosome. Cytoplasmic vesicle, autophagosome. Secreted. The precursor is cytosolic. In response to inflammasome-activating signals, such as ATP for NLRP3 inflammasome or bacterial flagellin for NLRC4 inflammasome, cleaved and secreted. IL1B lacks any known signal sequence and the pathway(s) of its secretion is(are) not yet fully understood (PubMed:24201029). On the basis of experimental results, several unconventional secretion mechanisms have been proposed. 1. Secretion via secretory lysosomes: a fraction of CASP1 and IL1B precursor may be incorporated, by a yet undefined mechanism, into secretory lysosomes that undergo Ca(2+)-dependent exocytosis with release of mature IL1B (PubMed:15192144). 2. Secretory autophagy: IL1B-containing autophagosomes may fuse with endosomes or multivesicular bodies (MVBs) and then merge with the plasma membrane releasing soluble IL1B or IL1B-containing exosomes (PubMed:24201029). However, autophagy impacts IL1B production at several levels and its role in secretion is still controversial. 3. Secretion via exosomes: ATP-activation of P2RX7 leads to the formation of MVBs containing exosomes with entrapped IL1B, CASP1 and other inflammasome components. These MVBs undergo exocytosis with the release of exosomes. The release of soluble IL1B occurs after the lysis of exosome membranes (By similarity). 4. Secretion by microvesicle shedding: activation of the ATP receptor P2RX7 may induce an immediate shedding of membrane-derived microvesicles containing IL1B and possibly inflammasome components. The cytokine is then released in the extracellular compartment after microvesicle lysis (PubMed:11728343). 5. Release by translocation through permeabilized plasma membrane. This may occur in cells undergoing pyroptosis due to sustained activation of the inflammasome (By similarity). These mechanisms may not be not mutually exclusive. - Information by UniProt
-
数据库链接
- Entrez Gene: 3553 Human
- Entrez Gene: 16176 Mouse
- Entrez Gene: 24494 Rat
- Omim: 147720 Human
- SwissProt: P01584 Human
- SwissProt: P10749 Mouse
- SwissProt: Q63264 Rat
- Unigene: 126256 Human
see all -
别名
- Catabolin antibody
- H1 antibody
- IFN beta inducing factor antibody
see all
图片
-
All lanes : Anti-IL-1 beta antibody [RM1009] (ab283818) at 1/1000 dilution
Lane 1 : Wild-type THP-1 Vehicle control: TPA (80 nM overnight) then LPS (0 ng/mL, 6 h) cell lysate
Lane 2 : Wild-type THP-1 TPA (80 nM overnight) then LPS (100 ng/mL, 6 h) cell lysate
Lane 3 : IL-1b knockout THP-1 Vehicle control: TPA (80 nM overnight) then LPS (0 ng/mL, 6 h) cell lysate
Lane 4 : IL-1b knockout THP-1 TPA (80 nM overnight) then LPS (100 ng/mL, 6 h) cell lysate
Lysates/proteins at 20 µg per lane.
Observed band size: 34 kDa why is the actual band size different from the predicted?Western blot: Anti-IL1B antibody [RM1009] (ab283818) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab283818 was shown to bind specifically to IL1B. A band was observed at 34 kDa in wild-type THP-1 cell lysates with no signal observed at this size in IL1B knockout cell line. To generate this image, wild-type and IL1B knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
-
All lanes : Anti-IL-1 beta antibody [RM1009] (ab283818) at 1/1000 dilution
Lane 1 : U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysate
Lane 2 : U-937 (Human histiocytic lymphoma monocyte) whole cell lysate
Lane 3 : U-937 treated with 100nM PMA for 2 days, then 1µg/ml LPS for 13h and add 5µg/ml BFA for another 4 h whole cell lysate
Lane 4 : RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate
Lane 5 : RAW 264.7 treated with 100ng/ml LPS for 4h and add 1µg/ml BFA for another 3 h whole cell lysate
Lane 6 : NR8383 (Rat lung macrophage (alveolar)) whole cell lysate
Lane 7 : NR8383 treated with 100ng/ml LPS for 4h and add 1µg/ml BFA for another 3 h whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Observed band size: 17.5,28,31 kDa why is the actual band size different from the predicted?Blocking and diluting buffer and concentration: 5% NFDM/TBST
Expression of IL-1 beta is induced by LPS treatment. 31-kDa precursor IL-1 beta, 28- and 17.5-kDa proteolytically cleaved IL-1 beta are observed.
The expression pattern and molecular weight observed is consistent with what has been described in the literature (PMID: 8446594, 19559631)
Exposure time: Lane 1-3: 3 min ; Lane 4-7: 70 seconds
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)
Immunohistochemical analysis of paraffin-embedded Mouse colon carcinom tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). Positive staining on the lamina propria in mouse colon carcinoma. The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)
Immunohistochemical analysis of paraffin-embedded RAW 264.7 cells labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). Positive staining on RAW 264.7 cells treated with LPS (100ng/ml for 4+3 hours) added BFA (1µg/ml for 3 hours) (Image A) and no staining on control RAW 264.7 (Image B). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)
Immunohistochemical analysis of paraffin-embedded Mouse lung tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). Positive staining on mouse lung treated with LPS (1ug/ml for 16 hours) and BFA (1ug/ml for 16h hours) (Image A) and no staining on control mouse lung was observed (Image B). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)
Immunohistochemical analysis of paraffin-embedded Mouse colon tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Negative control: no staining on mouse colon.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)
Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
Negative control: no staining on mouse spleen.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).
Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
-
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized U-937 cells labelling IL-1 beta with ab283818 at 1/50 (10.58 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing cytoplasmic staining in U-937 cells treated with Phorbol-12-myristate-13-acetate (100 nM) for 2 days, then replaced it with Lipopolysaccharides (1 µg/ml) for 13 h, with the addition of Brefeldin A (5 µg/ml) for the last 4 hours. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5 ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.
-
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized J774A.1 cells labelling IL-1 beta with ab283818 at 1/50 (10.58 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing cytoplasmic staining in J774A.1 cells treated with Lipopolysaccharides (100 ng/ml) for 4h, with the addition of brefeldin A (1 ug/ml) for the last 3 hours. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5 ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.
-
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized RAW 264.7 cells labelling IL-1 beta with ab283818 at 1/50 (10.58 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing cytoplasmic and nuclear staining in RAW 264.7 cells transfected with Lipopolysaccharides (100 ng/ml) for 4h, with the addition of brefeldin A (1 ug/ml) for the last 3 hours. (PMID:18490713, PMID:18939951). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.
-
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized U-937 (Human histiocytic lymphoma monocyte) treated with 100nM PMA for 2days then 1µg/ml LPS treated for 13h and add 5µg/ml BFA for another 4h (Red) / U-937 treated with 100nM PMA for 2days (Green) cells labelling IL-1 beta with ab283818 at 1/500 dilution (0.1ug) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
-
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized J774A.1 (Mouse reticulum cell sarcoma monocyte macrophage) treated with 100ng/ml LPS treated for 4h and add 1µg/ml BFA for another 3h (Red) / Untreated control (Green) cells labelling IL-1 beta with ab283818 at 1/500 dilution (0.1ug) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
-
IL-1 beta was immunoprecipitated from 0.35 mg U-937 (Human histiocytic lymphoma monocyte) treated with 100nM PMA for 2 days, then 1µg/ml LPS for 13h and add 5µg/ml BFA for another 4 h, whole cell lysate 10ug with ab283818 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab283818 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: U-937 (Human histiocytic lymphoma monocyte) treated with 100nM PMA for 2 days, then 1µg/ml LPS for 13h and add 5µg/ml BFA for another 4 h, whole cell lysate 10ug
Lane 2: ab283818 IP in U-937 treated with 100nM PMA for 2 days, then 1µg/ml LPS for 13h and add 5µg/ml BFA for another 4 h, whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab283818 in U-937 treated with 100nM PMA for 2 days, then 1µg/ml LPS for 13h and add 5µg/ml BFA for another 4 h, whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
-
IL-1 beta was immunoprecipitated from 0.35 mg RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate 10ug with ab283818 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab283818 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate 10ug
Lane 2: ab283818 IP in RAW 264.7 treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab283818 in RAW 264.7 treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
数据表及文件
-
SDS download
-
Datasheet download
文献 (32)
ab283818 被引用在 32 文献中.
- Chang J & Zhang W Remifentanil modulates the TLR4‑mediated MMP‑9/TIMP1 balance and NF‑κB/STAT3 signaling in LPS‑induced A549 cells. Exp Ther Med 25:79 (2023). PubMed: 36684659
- Ning Y et al. Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response. J Immunol Res 2023:7040113 (2023). PubMed: 36741232
- He N et al. Construction of IL-1 signalling pathway correlation model in lung adenocarcinoma and association with immune microenvironment prognosis and immunotherapy: Multi-data validation. Front Immunol 14:1116789 (2023). PubMed: 36865560
- Sheng M et al. Caspase 6/NR4A1/SOX9 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed fatty liver. Cell Death Discov 9:106 (2023). PubMed: 36977670
- Hu X et al. Voluntary Exercise to Reduce Anxiety Behaviour in Traumatic Brain Injury Shown to Alleviate Inflammatory Brain Response in Mice. Int J Mol Sci 24:N/A (2023). PubMed: 37047351